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Recent clinical andexperimental protocols forallogeneicbone marrowtransplan-
tation (BMT)' have demonstrated that Tcell depletion of bone marrow can dra-
matically reduce theincidence and severity ofgraft-vs.-host disease(1). One undesirable
effect ofsuch depletion, however, has been an increased incidence offailure ofal-
loengraftment, both early and in the late post-BMT period (1, 2). These problems
present a major obstacle to the application of clinical BMT across complete MHC
barriers. We have previously reported that the ability ofnon-T cell-depleted (non-
TCD) allogeneic BM inocula to increase levels of chimerism in murine radiation
bone marrow chimeras wasatleastpartly independentofa genetic potential forGVH
reactivity (2a). Thepresent studies addresspossible mechanisms whereby depletion
ofTcells from allogeneic BM mayresult in delayed failureofpreviouslyengraftedBM.
Previous studieshave demonstrated thatlethally irradiated mice reconstitutedwith
a mixture of TCD syngeneic and TCD allogeneic BM develop stable mixed lym-
phohematopoietic chimerism, with specific and permanent tolerance to donor and
recipientalloantigens (3-5). In addition, ifonly the syngeneic components ofmixed
BM inocula are TCD, the animals repopulate as 100% allogeneic chimeras and do
not develop clinical GVHD (6, 2a). The latter result appears to be due to aprotec-
tive effect against GVHD provided by the TCD syngeneic BM component (6-8).
Since chimerasproduced inthis manner appear healthy and survivelong-term, regard-
less ofwhether or not the allogeneic BM component is TCD, they provide a useful
model for examination of the effects of T cells in allogeneic BM inocula on long-
term tolerance. Using thismodel, wehave tested theability oftolerance in longterm
chimeras to withstand challenge with an intravenous inoculum containing normal,
nontolerant recipient strain splenocytes. The results indicate that tolerance is sur-
prisingly fragile in long-term mixed allogeneic chimeras prepared using TCD al-
logeneic BM. This was not due to the mixed chimerism per se, since tolerance in
allogeneic chimerasinitially reconstitutedwithTCDallogeneic BM alonewas equally
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1 Abbreviations used in this paper: A, allogeneic chimera; BM, bone marrow; BMT, BM transplanta-
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mera; nonTCD, non-T cell-depleted; RAMB, rabbit anti-mouse brain; TCD, T cell-depleted; WBC,
white blood cells.
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susceptible to the effects of such a challenge. In striking contrast to these results,
recipients of mixed marrow inocula in which the reconstituting allogeneic BM in-
oculum was nonTCD were completely resistant to the tolerance-breaking effects of
the same recipient strain splenocytes. Data are also presented concerning the depen-
dence of this phenomenon on potential GVH alloreactivity within the allogeneic
T cell population.
Materials and Methods
Animals.
￿
Male C57BL/IOSnJ (B10), B10.D2nSn (BIO.D2), and (C57BL/1OSn x B10.A)F,
[(B10 x B10.A)F,] mice were obtained from TheJackson Laboratory, Bar Harbor, ME. Male
(BIO.S/Sx x C57BL/IOSn)F, mice were bred in our own colony. Bone marrow chimeras were
maintained in a specific pathogen-free facility for at least 8 wk after BMT.
Chimera Preparation.
￿
Chimeras were prepared as previously described (5). Briefly, recip-
ient B10 mice, aged 12-16 wk, were lethally irradiated (1,025 rad, 8.6 min, "'Cs source) and
reconstituted on the same day with bone marrow obtained from the femora and tibiae of
B10 and B10.D2 or (B10 x BIO.A)F, donors aged 6-12 wk. T cell depletion was performed
using rabbit anti-mouse brain (RAMB) serum and guinea pigcomplement (C') (Gibco Labora-
tories, Grand Island, NY) as described (5). Animals were reconstituted with B10 and B10.D2
marrow in the following combinations: Mixed allogeneic (M) chimeras received 5 x 106
TCD B10 plus 15 x 106 TCD B10.D2 bone marrow cells (BMC); allogeneic (A) chimeras
received 15 x 106 TCD B10.D2 BMC ; completely allogeneic (CA) chimeras, so named be-
cause of the 100% allogeneic lymphohematopoietic repopulation (2a) received 5 x 106 TCD
BIO plus 15 x 106 nonTCD B10.D2 BMC . The designations used for chimeras prepared ac-
cording to these regimens are summarized in Table I.
Monoclonal Antibodies (mAb).
￿
FITC-conjugated 5F1 anti-Kb mAb (9) was used for de-
tecting cells of B10 origin. Biotinylated mAb 34-2-12 (10) with specificity for Dd was used
for detection of cells of B10.D2 or (B10 x B10.A)F, origin. FITC-conjugated Leu-4 (Becton
Dickinson & Co., Mountain View, CA) was used as an irrelevant antibody to test for back-
ground staining.
Flow Cytometry (FCM) Analysis.
￿
FCM analysis was performed as described (11) using a
modified Becton Dickinson & Co. FRCS 2. Data were displayed as cell frequency histograms
in which log fluorescence intensity was plotted on the x axis and cell number on they axis.
The percentage of cells considered positive after staining with a mAb was calculated using
a cut-off for positivity determined from the fluorescence profiles of negative and positive con-
trol populations, which were PBL from normal donor and recipient strain mice.
Staining of Splenocytes and Peripheral Blood Lymphocytes (PBL) of Chimeras.
￿
Initial PBL
phenotyping was performed 6-10 wk after BMT. Mice were bled and PBL were isolated as
described (4) . Cells were washed, then incubated with FITC or biotin-conjugated anti-Kb
or anti Dd (see above) mAb for 45 min at 4°C, then washed twice. For staining of biotinylated
mAb, a second incubation with FITC-avidin (Sigma Chemical Co., St. Louis, MO) for 30
min at 4°C was performed, cells were washed twice, then resuspended and analyzed using
FCM. Cell populations from negative and positive strains with respect to MHC haplotype
(i.e., PBL from normal donor and recipient strain mice) were used as negative and positive
controls, respectively, for staining with each mAb, and the percent of positively staining cells
in a chimera relative to the percent staining in the positive control population was calculated
using the formula: Relative percent staining = 100 x [(Experimental percent staining -
negative control percent staining)/ x 100% (positive control percent staining - negative control
percent staining)] . For those experiments in which increased nonspecific staining of ex-
perimental cell populations was observed, staining of the experimental cell population with
an irrelevant antibody (Leu-4-biotin) was substituted for staining of a cell population from
a negative strain with the test reagent.
Host-vs-Graft (HVG) Inocula.
￿
Sterile B10 spleen cell suspensions were prepared as described
(7). 2-50 x 106 cells were injected in a volume of 0.5 ml into the tail veins of chimeras 8-13
wk after BMT.SYKES ET AL.
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Skin Grafting
￿
6d afteradministration ofHVG inocula, full-thickness tail skin grafts were
placed on the lateral thorax of chimeras using the method of Billingham (12). Rejection was
considered complete when no viable skin was visible. Grafts that showed persistent signs of
inflammation and/or atrophy were considered to be undergoing chronic rejection.
White Blood Cell (WBC) Counts.
￿
Small samples of blood were obtained by tail bleeding
into a microfuge tube containing 2 U heparin sulfate (2 td). Red blood cell lysis was achieved
by incubation of a 10 pl aliquot of blood for 5 min in 250 ttlhypotonic ammonium chloride
buffer, and WBC were counted on a standard hemocytometer.
Results
Allogeneic TCellsin theReconstituting Marrow Inoculum Affect Stability ofLong-Term Toler-
ance. The levels of allogeneic chimerism resulting in animals reconstituted with
various combinations ofallogeneic TCD or nonTCD BM plus TCD syngeneic BM
are summarized in Table II. Appropriate levels of allogeneicchimerism after recon-
stitution with each BM combination were documented by PBL phenotyping of all
long-term chimeras before use in the studies reported here. Previous studies have
established that recipients of mixed marrow inocula containing TCD syngeneic plus
TCD or nonTCD allogeneic BM are specifically and permanently tolerant to donor
alloantigen in the strain combination used here, and that allogeneic chimerism is
permanent (3-6). To determine whether therewere differences in the nature oftoler-
ance observed in these types of chimeras, we challenged long-term stable chimeras
with normal (nontolerant) splenocytes syngeneic to the recipients. Tolerance was then
assessed by following the survival of donor-specific skin grafts placed 6 d after the
HVG inoculum was administered. In addition, the level of chimerism in the PBL
of these animals was assessed before, and at several time points after inoculation.
Unmanipulated long-term chimeras from the same experimental groups were used
as controls. 1310 chimeric recipients originally reconstituted with TCD 1310 plus TCD
B10.D2 BM (M chimeras) were compared with B10 chimeric recipients originally
reconstituted with TCD 1310 plus nonTCD 1310.132 BM (CA chimeras). An addi-
tional group, long-term B10 chimeric recipients originally reconstituted with TCD
1310.132 marrow alone (A chimeras), was included, since the level of chimerism
(ti98%) before HVG challenge of these animals more closely approximated that of
the CA recipients (100%) than did that of the M recipients (see Table II). Animals
in all three groups were inoculated intravenously with 0, 2 x 106, or 20 x 106 spleen
cells from normal 1310 donors.
The effects of these inocula on chimerism are shown in Fig. 1. The upper and
middle panels indicate that, throughout the 107-d follow-up period, the level of
chimerism remained stable in CA, A, and M chimeras receiving 0 or 2 x 106 B10
TABLE I
Designationsfor Radiation Bone Marrow Chimeras
" Donor bone marrow strains are indicated before the arrow; recipient is indi-
cated after the arrow.
Chimera Abbreviation Reconstitution`
Mixed M (1310+B10.D2)(TCD)-.1310
Allogeneic A B10.D2-TCD-BIO
Completely allogeneic CA 1310-TCD+BIO.D2-non-TCD-BlO664
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TABLE II
Donor Cell Chimerism In Radiation Chimeras Reconstituted
with Various Bone Marrow Inocula
Levels of donor cell chimerism'
Donor TCD
￿
Donor Non-TCD
Donor BM
￿
Donor BM plus
￿
Donor BM
￿
Donor BM plus
Reconstitution
￿
only
￿
TCD host-strain BM
￿
only
￿
TCD host-strain BM
%
￿
TO
Bl0.D2-+1110
￿
94-99 (A) b
￿
30-60 (M)
￿
100
￿
100 (CA)
(1110 x B10 .A)FI-+1110
￿
92-96
￿
60-65
￿
96-98
￿
90-94
' Chimerism determined usingmAb staining and FCM analysis . Numbers shown represent range for means
obtained from at least three experiments .
" Letters in parentheses indicate designations used for B10.D2-1110 chimeras in this paper (see Table I) .
spleen cells intravenously. However, the injection of 20 x 106 B10 spleen cells into
long-termM chimeras resulted in a marked decline in the level of chimerism in all
animals, with complete syngeneic repopulation in two of three animals . A similar
result wasobtained inAchimeras (Fig . 1, lower panel) . In contrast, the level ofchimerism
was not altered in any of the three CA chimeras receiving 20 x 106 B10 spleen cells .
Thus, the receiptofnonTCDallogeneic marrow at thetime ofBMTled to increased
stability of chimerism as indicated by increased resistance to the effects of anHVG
inoculum .
FIGURE 1.
￿
Effects on chimerism ofinoculation
of long-term chimeras with varying numbers of
fresh normal B10 splenocytes . Long-term estab-
lished mixed 1110TCD+B10.D2TCD -1110 (p),
allogeneic B10.D2TCD -+ B10 (A), and com-
pletely allogeneic B10TCD+1110.132-non-TCD -
1110 (O) chimeras received 0, 2 x 106 , or 20 x
106 fresh B10 splenocytes intravenously on day 0 .
The level of 1110.132 chimerism (percent H-2d)
was determined at the time points indicated by
staining ofPBL with fluorescence labeled mAb
and FCM analysis . Each curve represents data
from an individual chimera .SYKES ET AL.
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TABLE III
Donor Skin Graft Survival in Mixed, Completely Allogenic and Allogeneic
Chimeras After Inoculation With B10 Splenocytes
Number of 1310 spleen cells injected .
1 Rejected on day indicated.
S Chronic rejection ongoing on last day of observation, day 137.
II No evidence of rejection by last day of observation indicated .
The survival times of donor strain skin grafted 6 d after administration of 1310
spleen cells were also followed. All CA, M, and A chimeras receiving 0 or 2 x 106
1310 spleen cells retained BMW skin grafts without evidence of rejection for the
duration ofthe follow-upperiod (datanot shown). Skin graft survival times ofrecipients
of20 x 106 1310 spleen cells are shown in Table III (Exp. 1). In this group, all skin
grafts on CAchimeras remained perfectly intact throughout the observation period,
while three of three Mchimeras and two ofthree A chimeras rejected their grafts.
One A chimera showed no evidence ofrejection by termination offollow-up at day
137, and this animal was also the only A recipient of 20 x 106 1310 splenocytes that
did notdemonstratea reductionin thelevel ofallogeneicchimerismby day 107 (Fig.
1, lower panel).
These data indicated that CA chimeras were relatively resistant, compared with
MorA chimeras, to the tolerance-breaking effectsofnormal recipient strain spleno-
cytes. Althoughlossofchimerism correlated generallywith rejection ofdonor-specific
skin grafts, the rejection of skin grafts and loss ofchimerism in M and A chimeras
was slow and sometimes incomplete, and did not occur in every animal. We there-
fore repeated the experiment usingasomewhat larger B10 splenocyte inoculum, con-
sisting of 30 x 106 cells. We also wished to address the possibility that the loss of
chimerism in A and M but not in CA chimeras reflected the presence (in A and
M) or absence (in CA)ofsyngeneicstem cells inthe chimeras capable ofrepopulating
the animals after allogeneic hematopoietic elements were eliminated by the HVG
inoculum, rather than reflecting actual resistance to the tolerance-breaking proper-
ties of such an inoculum. In this case, the injection of1310 splenocytes would result
in amore severe and prolonged pancytopenia in CA chimeras than in MorA, since
Chimera
B10.D2 skin
after 1310 spleen
Exp. 1
(2 x 10')'
graft survival
cells were injected
Exp. 2
(3 x 10')
Mixed 1310-TCD+B10.D2-TCD-1310 116t
CRS
70
Completely allogeneic
1310-TCD+B10.D2-non-TCD-+1310 >13711 >100
>137 >100
>137 >100
Allogeneic B10.D2-TCD-+1310 CR 8
22 29
>137 15
12
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WBC COUNTS
￿
CHIMERISM
DAYS AFTER HVG INOCULUM
￿
DAYS AFTER HVG INOCULUM
FIGURE 2.
￿
Effects on chimerism and peripheral blood WBC counts of inoculation of 30 x 106
fresh B10 splenocytes into long-termA [B10.D2TCD--" B10] (-*-) and CA [B10TCD+B10.D2-
nonTCD - B10] (. . N . .) chimeras. B10 splenocytes were administered on day 0, and WBC
counts (left panel) and levels of chimerism (right panel) were determined at the time points indi-
cated, as described in Materials and Methods. Mean ± SE for three to five mice are shown
at each time point.
CA chimeras would lack stem cells capable of replacing the eliminated allogeneic
elements. We therefore followed peripheral blood WBC counts after administration
ofan HVG inoculum to CA and A chimeras. Since both groups began with fairly
similar levels of allochimerism, reduced WBC counts after this inoculation might
reflect destruction of chimeric lymphohematopoietic elements.
The results shown in Fig. 2 indicate that WBC counts fell in both groups after
injectionofB10 splenocytes, reachinganadirat 6-13 d. However, thisdrop wasmuch
more profound in A recipients (nadir 1,150 t 400 [SEM] WBC/p1), which experi-
enced severe leukopenia, thanin CArecipients (nadir 9,600 ± 400 [SEM] WBC/ul),
inwhich WBC counts did not differ significantly fromthose observed in unmanipu-
lated chimeras (13,400 ± 900 [SEM] WBC/p1). All A chimeras, and none of the
CA recipients, demonstrated a partial or complete loss ofchimerism. In addition,
A chimeras rejected B10.D2 skin grafts acutely, with rejection times ranging from
8 to 29 d(Table II, Exp. 2). In contrast, all CA chimeras retained B10.D2 skin grafts
permanently, withno sign ofrejection forthe duration ofthe 100-dfollow-up period.
All animals appeared healthy throughout the experiment.
In another experiment, three of three Mchimeras given 30 x 106 B10 spleen cells
also lost chimerism rapidly, with complete or nearly complete repopulation by B10
lymphopoietic cells by 48 d afterinoculation(data not shown) . Theseresultsdemon-
strated that T cells in reconstituting BM inocula lead to resistance in long-term
chimeras to the tolerance-breaking effects of normal recipient strain lymphocytes.
Effects ofHVG Inocula in FI into Parent Chimeras.
￿
We next attempted to determine
whether T cells in donor BM inocula would lead to resistance to breaking oftoler-
ance inlong-term chimeras ifthe potential for T cells in thedonor marrow inoculum
to react against the host(i.e., GVHreactivity) were minimized. This was done using
an F1 donor into parental recipient (F1 --' P) strain combination. As shown in Table
II, chimeras prepared by infusing either TCD or nonTCD (B10 x Bl0.A)F1 BM
alone into lethally irradiated B10 recipients repopulated as almost completely allo-
geneic chimeras, with slightly greater levels ofchimerism in recipients ofnonTCD
BM than in recipients ofTCD F1 BM, as previously reported (2a). The magnitudeNO HVG INOCULUM
SYKES ET AL.
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FIGURE 3 .
￿
Effects of HVG inocula on chimerism and WBC counts in long-term F, - P
chimeras. Long-term(1310 x B10.A)F,-nonTCD-1310(upper panel) and(1310 x B10.A)FlTCD
-B10(lowerpaneoeither underwentno additional manipulations (leftpanels) or received an intra-
venous inoculum containing 30 x 106 B10 splenocytes on day0 (11 wk after BMT) (rightpanels).
Total peripheral WBC counts (. . / . .) and percent F, chimerism (f), determined as de-
scribed in Materials andMethods, are shown at various time points afterinoculation with 1310
splenocytes. Each point represents mean t SE of results from three or four animals.
and direction ofthe difference in levels ofchimerism between the former and the
latter group were similarto those between the CA and Achimeras discussed above
(see Table II). 11 wk after BMT, Fl-nonTCD -P and F1TCD -P chimeras were
either inoculated with 30 x 106 B10 spleen cells (test group) or left unmanipulated
(control group). WBC counts, chimerism, and skin graft survival were followed. As
shown in Fig. 3, a significant drop in WBC counts in Fl - P chimeras inoculated
with B10 splenocytes was observed in injected chimeras and not in unmanipulated
controls, regardless ofwhether or not the initial F1 bone marrow inoculum had been
T cell depleted. In addition, levels ofF1 chimerism declined gradually in both F1-
TCD and F1-nonTCD-reconstituted mice inoculated with B10 splenocytes. This
decline was slightly more pronounced in FiTCD than in F1-nonTCD chimeras,
andone animal in the former group lost its chimerism completely. Uninjectedcontrol
animals in both groups maintained their levels of Fl chimerism throughout the
follow-up period.
Donor strain F1 skin grafts were partially or completely rejected by injected ani-
mals in both groups, regardless ofwhether ornot the original F1 BM inoculum had
been TCD (Table IV). In contrast, uninjected control animals in both groups re-
tained donor F1 skin grafts in perfect condition permanently (Table IV). Injected
and uninjected animals in both groups rejected third-party (1310. S x B10)F1 skin
grafts briskly and with equal efficiency (data not shown), indicating that chimeras
were immunocompetent and, ifleftunmanipulated, were specifically tolerant ofdonor
(1310 x B10.A)F1 alloantigen.
Overall, these results indicated that animals reconstituted with nonTCD semial-
logeneic BM were not substantially more resistant to the tolerance-breaking effects668
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TABLE IV
Effects of HVG Inocula on Donor Skin Graft Survival in FI-P Chimeras
* Animals received 3 x 107 fresh B10 splenocytes on day -6.
1 Grafts in perfect condition at termination of follow-up period, 148 d.
4 Grafts rejected on day indicated.
II Chronic rejection ongoing at termination of follow-up period, 148 d .
Animal died on day indicated with skin graft intact.
ofrecipient strain lymphocytes than were animals reconstituted withTCDBM. How-
ever, loss of chimerism, skin graft rejection, and decline in WBC counts after ad-
ministration of30 x 106 B10 spleen cells were less dramatic in F1TCD -B10 than
was observed in B10.D2TCD -B10 chimeras (Fig. 2; Table III, Exp. 2). The result
in Fl - B10 chimeras was therefore confirmed in a repeat experiment in which
larger numbers ofB10 spleen cells were administered. More rapid rejection ofskin
grafts and loss ofchimerism were observed in five FiTCD -" B10 and five Fl-non-
TCD -B10 chimeras inoculated with 50 x 106 B10 spleen cells. There were no ap-
parent differences in rates of graft rejection and loss of chimerism between animals
originally reconstituted with TCD versus those reconstituted with nonTCD Fl
marrow (data not shown). Five control chimeras ofeach type which received saline
injections retainedskingrafts and chimerism permanently(datanot shown). Incontrast
to results obtained in P1 -P2 chimeras, therefore, Tcells in reconstitutingmarrow
inocula did not confer resistance to breaking of tolerance in Fl - P chimeras.
Discussion
The model described in this paper was designed to determine theeffects ofT cells
present in reconstituting allogeneic BM inocula on the stabilityoftolerance to donor
antigen inlong-termradiation bonemarrowchimeras. Wehave previously observed
that coadministration ofTCD syngeneic BM along with nonTCD allogeneic BM
to lethally irradiated recipients provides protection from GVHDwhile still allowing
100% allochimerismto develop(6, 8). These apparently healthy chimeras were there-
fore suitable for long-term studies. The effects of HVG inocula in such chimeras
were compared withthose inlong-termchimeras reconstitutedwithTCD allogeneic
BM, with or without TCD syngeneic BM. Surprisingly, tolerance was quite easily
broken in recipients in which the original allogeneic marrow inoculum had been
TCD. 20 x 106 recipient strain splenocytes were sufficient to break tolerance in most
M and A chimeras, as evidenced by a reduction in or complete loss of chimerism,
and slow, partial, or complete rejection of donor-specific skin grafts. CA chimeras,
which had receivedthe same reconstituting mixed marrow inoculum asthe Mgroup,
except that the allogeneic marrow was nonTCD, were completely resistant to these
tolerance-breaking effects.
Further evidence for the relative sensitivity ofA compared with CA chimeras to
Skin graft survival
Recipients of B10
Chimera Uninjected controls splenocytes*
d
(B10 x B10.A)Ft-TCD-B10 >148, >148, >1481 91§, CRII148, 52
(B10 x B10.A)Ft-non-TCD-Bl0 >148, >148, >148, >1421 129, 133, 21SYKES ET AL.
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the alloaggressive effects ofHVG inocula was the marked leukopenia in the former
and not the latter group in the early period after inoculation with 30 x 106 B10
splenocytes (Fig. 2). The higher WBC counts inCAchimeras donot reflect prolifer-
ation of administered host strain splenocytes, since PBL of CA chimeras typed in
this early period were solely ofdonor phenotype (Fig. 2). Recovery ofWBC counts
after their dramatic decline in A chimeras was associated with repopulation by cells
of recipient H-2 phenotype, while CA chimeras remained completely allogeneic
throughout the experiment. This repopulation ofA chimeras may have been derived
from stem cells already present in the chimera at the time ofHVG inoculation, or
from stem cells present in the spleen cell HVG inoculum itself. In this experiment,
donor skin grafts were rapidly rejected by A chimeras and permanently accepted
by CA chimeras. All three parameters (leukopenia, loss ofchimerism, and rejection
of donor skin grafts) therefore confirm the greater sensitivity ofA compared with
CA chimeras to the alloaggressive effects of HVG inocula.
These results demonstrate that : (a) Tolerance to donor alloantigen, which is per-
manent in otherwise unmanipulated wholebodyirradiation bone marrow chimeras
prepared with TCD allogeneic BM, can be broken by inoculation with relatively
small numbers ofnontolerant recipient strain lymphocytes. Loss oftolerance is ac-
companiedby aloss ofdonor chimerism regardless ofwhetheror not the initial level
ofdonor chimerism was almost complete (A chimeras) or was only partial (M chi-
meras); and (b) one or more cell populations in donor marrow, removed during T
cell depletion, confer resistance in long-term chimeras to such tolerance-breaking
effects of recipient strain lymphocytes.
There are severalpossibleexplanations forthe abilityofallogeneic Tcellsin recon-
stituting marrow inocula to confer resistance to breaking of tolerance. Suppressor
cells in the original reconstituting marrow inoculum, possibly similar to those im-
plicatedin several rodent models ofexperimentally induced tolerance (13-15), might
play a role in resisting breaking of tolerance. Resistance to breaking of tolerance
in CA chimeras might also be due to anti-host Tcell reactivity ofallogeneic T cells
administered in the original reconstituting marrow inoculum. Such T cells, after
being primed in vivo by B10 host antigen, might eliminate inoculated B10 spleno-
cytes before the latter population could effect breaking oftolerance. Indeed, anti-host
CTL activity can be detected in splenocyte populations from some long-term CA
chimeras (6). This possibility is strongly supported by findings in F1 - P chimeras,
in which tolerance is broken with equal facility in recipients ofnonTCD vs. TCD
Fj marrow (Fig. 3, Table IV), since in this strain combination the potential for
GVH T cell reactivity is greatly diminished.
In studiesinvolvinga Pl -P2 strain combination, weused chimeras reconstituted
with nonTCD allogeneic plus TCDsyngeneic BM, since animals reconstituted with
nonTCD allogeneic BM alone tend to show increased early mortality (6) and are
therefore not suitable for long-term studies. However, thepresenceofTCD syngeneic
BM in the original reconstituting inoculumdid not appear toenhance theresistance
to HVG inocula, since animals reconstituted with TCD syngeneic BM in addition
to TCD allogeneic BM were equally or more susceptible to breaking oftolerance
than animals reconstituted with TCD allogeneic marrow alone. When studying an
Fi into parent combination, we elected to compare animals reconstituted with F1
(TCD vs. nonTCD) BM alone, rather than a mixed F1/syngeneic BM combination,670
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since the relative levels of chimerism in the former groups most closely paralelled
those of CA vs. A chimeras (Table II).
CA chimeras are clinically free of GVHD (6), and in vitro studies (Sykes, M.,
et al., unpublished data)have provided no evidence for GVH-related immunodefi-
ciency (16, 17). Thus, GVH reactivity required to prevent the alloaggressive effects
of injected recipient strain lymphocytes may be quantitatively or qualitatively in-
sufficient to produce either clinical GVHD or in vitro evidence for GVH-related
immunodeficiency.
It is possible that the resistance to breaking oftolerance attributed to T cells in
allogeneic reconstituting BM inocula is mediated by a cell population other than
T lymphocytes, since the RAMB serum used for T cell depletion may eliminate
additional non-T cell BM subpopulations. Studies performed to date suggest that
stem cells are not selectively depleted but that NK cells in bone marrow are elimi-
nated by RAMB/C treatment (2a). Since similar protection from HVG inocula by
RAMB/C-sensitive cells in donor BM inocula was not observed in the Fl - P com-
bination, the effects in Pl - P2 chimeras are most likely to be related to potential
GVH reactivity, which is an established property of T cells (18, 19).
Attempts tobreak toleranceinmurine whole body irradiationbone marrow chimeras
have not, to ourknowledge, been previouslyreported. The ability to breakexperimen-
tally inducedtolerance in neonatally tolerized mice, however, was first demonstrated
by Billingham et al. (20) and has subsequently been demonstrated in neonatally
tolerized rats (21, 22). The numbers oflymphoid cells required to break neonatally
induced tolerance in mice (23, 24) were much greater than those required in our
irradiationTCD-BM chimeras. In these earlier reports, skin grafting wasperformed
long before recipient strain lymphocytes were administered, and it is possible that
changes in the grafts themselves might render them less susceptible to rejection by
the time an HVG inoculum is adminstered (25). Since we grafted donor-specific
skin 6 d after administration ofrecipient strain splenocytes, prior adaptation ofthe
graft could not have played a role. The strikingly different susceptibilities ofneona-
tally tolerized mice and radiation bone marrow chimeras to breaking oftolerance
might also reflect inherent differences in the mechanisms maintaining tolerance in
the two models.
The small number ofnormal recipient strain lymphocytes (one-fifth to one-third
spleen equivalent) required to break tolerance in radiation chimeras reconstituted
with TCD allogeneic BM suggests that if suppression plays any role in maintaining
tolerance to donor antigen, it is not sufficiently potent to suppress the activity of
a relatively smallnumber ofadditional lymphocytes reactive todonorantigen. Thus,
clonal deletion may be the dominant mechanism maintaining tolerance to donor
alloantigen in radiationbonemarrow chimeras preparedwith TCD allogeneic marrow.
We have recently demonstrated that much of the ability ofallogeneic T cells in
allogeneic or mixed allogeneic bone marrow inocula to increase the level ofallochi-
merism is independent oftheirpotential GVH reactivity (2a). The observation that
resistance to breaking of tolerance is associated with T cells potentially capable of
producing GVHD therefore implies thatthesetwo effects maybemediated by different
mechanisms, and/or different cell subpopulations. Both phenomena might be im-
portant clinically, since failure ofengraftment after reconstitution with TCDallogeneic
bone marrow has been observed long after initial engraftment had been achievedSYKES ET AL.
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(1). Our results indicate that the mechanisms maintainingtolerance todonorantigen
in radiation chimeras constructed with TCD allogeneic BM are fragile and cannot
resist the addition of relatively small numbers of nontolerant lymphocytes. In the
clinical situation, small numbers ofhost T cells might escape the ablative regimen
used forpreparation forBMT (26), andcould subsequently expand tocause delayed
rejection ofa donor marrow allograft. This might be prevented if the original BM
inoculum contained anti-host-reactive T cells capable of eliminating residual host
lymphocytes. Regardless ofthemechanismsdeterminingmarrowallograftrejection
at different times, our results indicate that a small number ofT cells in allogeneic
BM inocula might be sufficient to prevent both early and late marrow rejection.
The use ofa mixed syngeneic (TCD) and allogeneic (nonTCD or partially TCD)
marrow inoculum might permit achievement of this goal since syngeneic marrow
appears to provide protection from GVHD (6-8) while permitting development of
complete allochimerism inassociationwith stable specific toleranceto donor antigen.
Summary
The ability ofnormal recipient-type lymphocytes tobreak tolerance in long-term
allogeneic radiation chimeras has been investigated. Reconstitution of lethally ir-
radiated mice with a mixture of syngeneic and allogeneic T cell-depleted (TCD)
bone marrow(BM) haspreviously been shown toleadto mixed chimerism andper-
manent, specific tolerance to donor and host alloantigen (3-5). If allogeneic Tcells
are not depleted from the reconstituting inoculum, complete allogeneic chimerism
results; however, no clinical evidence for GVHD is observed, presumably due to
the protective effect provided by syngeneic TCD BM. This model has now been
used to study the effects of allogeneic T cells administered in reconstituting BM
inocula on stability oflong-term tolerance. We have attempted to break tolerance
in long-term chimeras originally reconstituted with TCD or nonTCD BM by
challengingthem with inoculacontaining normal, nontolerant recipient strain lym-
phocytes. Tolerancewas broken with remarkable ease in recipients ofmixedmarrow
inocula in which both original BM components were TCD. In contrast, tolerance
in chimeras originally reconstituted with nonTCD allogeneic BM was not affected
by such inocula. Susceptibility to loss of chimerism and tolerance was not related
to initial levels ofchimerism per se, but rather to Tcell depletion ofallogeneic BM,
since chimeras reconstituted withTCDallogeneic BM alone (mean level ofallogeneic
chimerism 98%) were as susceptible as mixed chimeras to the tolerance-breaking
effects of such inocula. The possible contribution of GVH reactivity to this resis-
tance was investigated using an F1 into parent strain combination. In these animals,
the use ofnonTCD Fl BM inocula for reconstitution did not lead to resistance to
the tolerance-breaking effects ofrecipient strain splenocytes. These results suggest
that the ability ofT cells in allogeneic BM inocula to confer resistance to late graft
failure may be related to their graft-vs.-host reactivity, even in situations in which
they do not cause clinical GVHD. These findings may have relevance to the mecha-
nism whereby T cell depletion ofallogeneic BM leads to an increased incidence of
late graft failure in clinical BM transplantation situations.
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